Synthesis of 1,2,3-triazole analogs of CFTR potentiator VX-770

被引：0
|
作者：
Ody, Britton [1 ]
机构：
[1] Berry Coll, Chem & Biochem, Mt Berry, GA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
324
引用
收藏
页数：1
相关论文
共 50 条
  • [1] VX-770, AN INVESTIGATIONAL CFTR POTENTIATOR, ACTS ON MULTIPLE CFTR FORMS IN VITRO
    Yu, H.
    Burton, B.
    van Goor, F.
    PEDIATRIC PULMONOLOGY, 2010, : 318 - 319
  • [2] VX-770, a potent, selective, and orally bioavailable potentiator of CFTR gating
    Van Goor, F.
    Hadida, S.
    Grootenhuis, P.
    PEDIATRIC PULMONOLOGY, 2007, : 289 - 289
  • [3] Structural Consequences of the 1,2,3-Triazole as an Amide Bioisostere in Analogues of the Cystic Fibrosis Drugs VX-809 and VX-770
    Doiron, Jake E.
    Le, Christina A.
    Bacsa, John
    Breton, Gary W.
    Martin, Kenneth L.
    Aller, Stephen G.
    Turlington, Mark L.
    CHEMMEDCHEM, 2020, 15 (18) : 1720 - 1730
  • [4] Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
    Van Goor, Fredrick
    Hadida, Sabine
    Grootenhuis, Peter D. J.
    Burton, Bill
    Cao, Dong
    Neuberger, Tim
    Turnbull, Amanda
    Singh, Ashvani
    Joubran, John
    Hazlewood, Anna
    Zhou, Jinglan
    McCartney, Jason
    Arumugam, Vijayalaksmi
    Decker, Caroline
    Yang, Jennifer
    Young, Chris
    Olson, Eric R.
    Wine, Jeffery J.
    Frizzell, Raymond A.
    Ashlock, Melissa
    Negulescu, Paul
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (44) : 18825 - 18830
  • [5] LONG-TERM SAFETY AND EFFICACY OF INVESTIGATIONAL CFTR POTENTIATOR, VX-770, IN SUBJECTS WITH CF
    McKone, E. F.
    Borowitz, D.
    Drevinek, P.
    Griese, M.
    Konstan, M. W.
    Wainwright, C. E.
    Ratjen, F.
    Sermet-Gaudelus, I
    Rodriguez, S.
    Yen, K.
    Davies, J. C.
    PEDIATRIC PULMONOLOGY, 2011, : 284 - 284
  • [6] OPPOSING EFFECT OF THE VX-770 GATING POTENTIATOR ON THE CORRECTED ΔF508-CFTR FUNCTION AND PROCESSING
    Veit, Guido
    Avramescu, Radu G.
    Perdomo, Doranda
    Phuan, Puay-Wah
    Bagdany, Miklos
    Pirjo, Apaja
    Borot, Florance
    Szollosi, Daniel
    Wu, Yu-Sheng
    Finkbeiner, Walter E.
    Hegedus, Tamas
    Verkman, A. S.
    Lukacs, Gergely L.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 118 - 119
  • [7] Effect of VX-770, a Cystic Fibrosis Transmembrane Conductance (CFTR) Potentiator, on Bone Phenotypes in ADO2 Mice
    Alam, Imranul
    Gerard-ORiley, Rita
    Acton, Dena
    Hong, Jung Min
    Bruzzaniti, Angela
    Econs, Michael J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 265 - 265
  • [8] EFFECT OF VX-770, A CFTR POTENTIATOR, ON SPIROMETRY AND QOL ASSESSMENT IN SUBJECTS WITH CF AND THE G551D-CFTR MUTATION
    Boyle, M.
    Clancy, J. P.
    Rowe, S. M.
    Durie, P.
    Dunitz, J.
    Konstan, M. W.
    Hornick, D.
    Sagel, S. D.
    Ramsey, B.
    Dong, Q.
    Ordonez, C.
    Campbell, P.
    Ashlock, M.
    Accurso, F. J.
    PEDIATRIC PULMONOLOGY, 2009, : 287 - 287
  • [9] VX-809, AN INVESTIGATIONAL CFTR CORRECTOR, IN COMBINATION WITH VX-770, AN INVESTIGATIONAL CFTR POTENTIATOR, IN SUBJECTS WITH CF AND HOMOZYGOUS FOR THE F508DEL-CFTR MUTATION
    Boyle, M. P.
    Bell, S.
    Konstan, M. W.
    McColley, S. A.
    Wisseh, S.
    Spencer-Green, G.
    PEDIATRIC PULMONOLOGY, 2011, : 287 - 287
  • [10] Discovery of VX-770 (Ivacaftor), a CFTR potentiator for the treatment of cystic fibrosis in G551D patients
    Grootenhuis, Peter D. J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
12345